SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-12-004236
Filing Date
2012-01-27
Accepted
2012-01-27 17:25:21
Documents
1
Period of Report
2012-01-25

Document Format Files

Seq Description Document Type Size
1 2012 OPTION GRANT rrd331684.html 4  
1 2012 OPTION GRANT rrd331684.xml 4 10389
  Complete submission text file 0001181431-12-004236.txt   11839
Mailing Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277
Business Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Issuer) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address C/O CHELSEA THERAPEUTICS, INC. 13950 BALLANTYNE CORPORATE PL, UNIT 325 CHARLOTTE NC 28277
Business Address
Schmidt Keith (Reporting) CIK: 0001389235 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51462 | Film No.: 12552813